Cohen Cheryl
- SEC CIK
- 0001529371
In the past year, 1 open-market sale filing worth $1.25M and no purchases.
Current role at each company
- IBRX ImmunityBio, Inc.Directoras of Jul 6, 2026
- CLDX Celldex Therapeutics, Inc.Directoras of Jun 29, 2026
- LITS Lite Strategy, Inc.Directoras of Jul 7, 2022
- WHWK Whitehawk Therapeutics, Inc.Directoras of Jul 2, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.25M
- 1 filing
- Net
- −$1.25M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Cohen Cheryl as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IBRX ImmunityBio, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 (view filing)8:26 PM ET | Jul 2 | 4 days | Cohen CherylDirector | SSale | −131.2K | $9.50 | −$1.25M | −51.1%125.4K after | 10b5-1 |
| Aug 24, 2021 (view filing) | Aug 20-23 | 4 days | Cohen CherylDirector | SSale | −24.8K | $10.07 | −$249.5K | −11.0%200.6K after | 2 lots |
| Aug 19, 2021 (view filing) | Aug 17-18 | 2 days | Cohen CherylDirector | SSale | −45.5K | $10.12 | −$460.6K | −16.8%225.4K after | 2 lots |